INTRODUCTION: Gastroesophageal reflux is the most important factor in the development of Barrett's metaplasia. The effect of acid reflux is commonly accepted today, but there is controversy about the role of non-acid reflux. With introduction of combined esophageal pH-impedance monitoring, a precise diagnostic test for acid and non-acid reflux is now available. METHODS: Ninety two consecutive patients (33 women) off acid-suppressive therapy underwent diagnostic work-up for suspected gastroesophageal reflux disease including upper-GI endoscopy, esophageal manometry, barium swallow, and combined esophageal pH-impedance monitoring. Patients were subdivided into three groups according to symptoms and endoscopic appearance: typical symptoms without esophagitis (n = 28; NERD); erosive esophagitis (n = 52, ERD), and patients with intestinal metaplasia (n = 12, BE). RESULTS: Pathologic acid reflux during pH-metry was found in 35.7%, 63.5%, and 75.0% for NERD, ERD, and BE patients, respectively (P = 0.022). Likewise, the percentage of time pH < 4 rose significantly during upright, supine, and total phases. In contrast, combined pH-impedance monitoring showed no significant difference between groups for the number of acid reflux events and for percentage of acid bolus reflux time. However, BE patients had significantly more non-acid reflux events and a higher percentage of non-acid bolus reflux time during the supine (P = 0.043, P = 0.020, respectively), but not during the upright phase (P = 0.740, P = 0.730, respectively). CONCLUSION: Patients with BE are exposed to increased supine non-acid reflux and to increased acid reflux during upright and supine phases. This observation supports the concept that nocturnal non-acid reflux may play a role in the pathogenesis of BE.
INTRODUCTION: Gastroesophageal reflux is the most important factor in the development of Barrett's metaplasia. The effect of acid reflux is commonly accepted today, but there is controversy about the role of non-acid reflux. With introduction of combined esophageal pH-impedance monitoring, a precise diagnostic test for acid and non-acid reflux is now available. METHODS: Ninety two consecutive patients (33 women) off acid-suppressive therapy underwent diagnostic work-up for suspected gastroesophageal reflux disease including upper-GI endoscopy, esophageal manometry, barium swallow, and combined esophageal pH-impedance monitoring. Patients were subdivided into three groups according to symptoms and endoscopic appearance: typical symptoms without esophagitis (n = 28; NERD); erosive esophagitis (n = 52, ERD), and patients with intestinal metaplasia (n = 12, BE). RESULTS: Pathologic acid reflux during pH-metry was found in 35.7%, 63.5%, and 75.0% for NERD, ERD, and BE patients, respectively (P = 0.022). Likewise, the percentage of time pH < 4 rose significantly during upright, supine, and total phases. In contrast, combined pH-impedance monitoring showed no significant difference between groups for the number of acid reflux events and for percentage of acid bolus reflux time. However, BE patients had significantly more non-acid reflux events and a higher percentage of non-acid bolus reflux time during the supine (P = 0.043, P = 0.020, respectively), but not during the upright phase (P = 0.740, P = 0.730, respectively). CONCLUSION:Patients with BE are exposed to increased supine non-acid reflux and to increased acid reflux during upright and supine phases. This observation supports the concept that nocturnal non-acid reflux may play a role in the pathogenesis of BE.
Authors: S Mattioli; V Pilotti; V Felice; A Lazzari; R Zannoli; M L Bacchi; P Loria; A Tripodi; G Gozzetti Journal: Dig Dis Sci Date: 1990-08 Impact factor: 3.199
Authors: S Oberg; T R DeMeester; J H Peters; J A Hagen; J J Nigro; S R DeMeester; J Theisen; G M Campos; P F Crookes Journal: J Thorac Cardiovasc Surg Date: 1999-03 Impact factor: 5.209
Authors: Anne L Krarup; Søren S Olesen; Peter Funch-Jensen; Hans Gregersen; Asbjørn M Drewes Journal: World J Gastroenterol Date: 2011-01-28 Impact factor: 5.742
Authors: Jennifer Drahos; Winnie Ricker; Ruth Parsons; Ruth M Pfeiffer; Joan L Warren; Michael B Cook Journal: J Clin Gastroenterol Date: 2015-04 Impact factor: 3.062
Authors: Ayman O Nassr; Syeda Nadia Shah Gilani; Mohammed Atie; Tariq Abdelhafiz; Val Connolly; Neil Hickey; Thomas Noel Walsh Journal: J Gastrointest Surg Date: 2011-04-12 Impact factor: 3.452
Authors: Martin Riegler; Sebastian F Schoppman; Luigi Bonavina; David Ashton; Thomas Horbach; Matthias Kemen Journal: Surg Endosc Date: 2014-08-30 Impact factor: 4.584
Authors: Joachim H Schneider; Markus A Küper; Alfred Königsrainer; Björn L D M Brücher Journal: J Gastrointest Surg Date: 2009-09-12 Impact factor: 3.452